10+10+30 Infant Vaccines Communication Via Radio in Ethiopia

NCT04913714 | Completed

• 1 other identifier: OPP1191306
• Study Type: interventional
• Target: 1,320
• Locations: 2 countries
• Sites: 2

Brief Summary

A cohort study to investigate the effectiveness of radio intervention comprising 10-minute of drama, 10-minute of discussion led by community extension workers, and 30-minute phone-in from listeners on childhood vaccination coverage and timeliness

Conditions

Infant ALL

Outcome Measures

Primary Outcomes (1)

• Penta 3 vaccine coverage of infant

  Infant's vaccination record or mother's recall based on interviewer-administered questionnaire

  up to 3 weeks after the intervention ends

Secondary Outcomes (7)

• Timeliness of infant vaccines

  up to 3 weeks after the intervention ends

• Full coverage of infant vaccines

  up to 3 weeks after the intervention ends

• Perceived barriers to vaccination

  Immediately before intervention starts, and up to 3 weeks after the intervention ends

• Perceived susceptibility to vaccine-preventable diseases in children

  Immediately before intervention starts, and up to 3 weeks after the intervention ends

• Perceived benefits of infant vaccines

  Immediately before intervention starts, and up to 3 weeks after the intervention ends

Study Arms (2)

Intervention

ACTIVE COMPARATOR

A district where the radio intervention will be broadcast.

Behavioral: 3-month radio intervention on infant vaccination

Control

NO INTERVENTION

A district where the radio intervention will not be broadcast.

Interventions

3-month radio intervention on infant vaccination BEHAVIORAL

Radio intervention comprising 10-minute drama, 10-minute discussion of the drama by trained health extension workers and 30-minute phone-in from listeners

Intervention

Eligibility Criteria

• Age: 1 Day - 5 Weeks
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17)

You may qualify if:

• Mother, with infant of at most 5 weeks old; Lives in the study district; Consents to participate in study

You may not qualify if:

• Mother, with infant of more than 5 weeks old; Does not live in study district; Does not consent to participate in study

Sponsors & Collaborators

• Syracuse University: lead
• Jimma University: collaborator
• Texas A&M University: collaborator
• Bill and Melinda Gates Foundation: collaborator

Study Sites (2)

Syracuse University

Syracuse, New York, 13244, United States

Location

Jimma University

Jimma, Ethiopia

Location

Study Officials

• Bernard Appiah, DrPH

  Syracuse University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NON RANDOMIZED
• Masking: SINGLE
• Who Masked: OUTCOMES ASSESSOR
• Masking Details: Data analyst did not know which group received the intervention
• Purpose: OTHER
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: May 26, 2021
• First Posted: June 4, 2021
• Study Start: October 13, 2020
• Primary Completion: January 31, 2021
• Study Completion: January 31, 2021
• Last Updated: June 4, 2021

Record last verified: 2021-06

Data Sharing

• IPD Sharing: Will share
• Time Frame: After publication
• Access Criteria: Will be accessible as part of open access publishing

Locations

ET (1); US (1)